The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bioprocessing Systems-Global Market Insights and Sales Trends 2024
Synopsis
Manufacturing biologics is a complicated process and thus generally are outsourced by the manufacturers. Bioprocessing is the manufacturing process which helps in producing bio-based products such as vegetable oils, and fatty acids. The major applications of bioprocess industry are vaccines, tissue engineering, biosensors, and biopharmaceuticals. Bioprocessing also is known as biopharmaceutical manufacturing is a bioprocess used for the production of therapeutic cells.
The global Bioprocessing Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bioprocessing Systems in various end use industries. The expanding demands from the Vaccine Development, Cell Therapy and Plant Cell Cultivation, Filters and Tissue Engineering, are propelling Bioprocessing Systems market. Upstream, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Downstream segment is estimated at % CAGR for the next seven-year period.
The global bioprocessing systems market witnessed significant growth owing to increasing demand for bio-based products. The heavy demand for such systems by the industries such as food, pharmaceuticals, neutraceuticals, chemicals and polymers coupled with automation in the industrial process minimizing human errors have propelled the growth of global bioprocessing market. Moreover, the factors such as rising demand for biopharmaceutical production, increasing symptoms of chronic diseases, low manufacturing costs as compared to the artificial source of materials and improvisation of infrastructure in life science research has triggered the global bioprocessing systems during the forecast period 2017-2027. Growing demand for the single –use systems of the bioprocessing systems is expected to gain traction during the forecast period which is supposed to augment the global bioprocessing system market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bioprocessing Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bioprocessing Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bioprocessing Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bioprocessing Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bioprocessing Systems covered in this report include Lonza, Pall Corporation, GE Healthcare, Nordson MEDICAL's, Thermo Fisher Scientific, EMD Millipore Corporation and PBS Biotech, etc.
The global Bioprocessing Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lonza
Pall Corporation
GE Healthcare
Nordson MEDICAL's
Thermo Fisher Scientific
EMD Millipore Corporation
PBS Biotech
Global Bioprocessing Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bioprocessing Systems market, Segment by Type:
Upstream
Downstream
Single Use
Integrated
Global Bioprocessing Systems market, by Application
Vaccine Development
Cell Therapy and Plant Cell Cultivation
Filters
Tissue Engineering
Biosensors
Bioreactors and Mixers
Plasma Fractionation
Chromatography
Bio-therapeutic Molecule Production
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bioprocessing Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Manufacturing biologics is a complicated process and thus generally are outsourced by the manufacturers. Bioprocessing is the manufacturing process which helps in producing bio-based products such as vegetable oils, and fatty acids. The major applications of bioprocess industry are vaccines, tissue engineering, biosensors, and biopharmaceuticals. Bioprocessing also is known as biopharmaceutical manufacturing is a bioprocess used for the production of therapeutic cells.
The global Bioprocessing Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bioprocessing Systems in various end use industries. The expanding demands from the Vaccine Development, Cell Therapy and Plant Cell Cultivation, Filters and Tissue Engineering, are propelling Bioprocessing Systems market. Upstream, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Downstream segment is estimated at % CAGR for the next seven-year period.
The global bioprocessing systems market witnessed significant growth owing to increasing demand for bio-based products. The heavy demand for such systems by the industries such as food, pharmaceuticals, neutraceuticals, chemicals and polymers coupled with automation in the industrial process minimizing human errors have propelled the growth of global bioprocessing market. Moreover, the factors such as rising demand for biopharmaceutical production, increasing symptoms of chronic diseases, low manufacturing costs as compared to the artificial source of materials and improvisation of infrastructure in life science research has triggered the global bioprocessing systems during the forecast period 2017-2027. Growing demand for the single –use systems of the bioprocessing systems is expected to gain traction during the forecast period which is supposed to augment the global bioprocessing system market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bioprocessing Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bioprocessing Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bioprocessing Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bioprocessing Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bioprocessing Systems covered in this report include Lonza, Pall Corporation, GE Healthcare, Nordson MEDICAL's, Thermo Fisher Scientific, EMD Millipore Corporation and PBS Biotech, etc.
The global Bioprocessing Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lonza
Pall Corporation
GE Healthcare
Nordson MEDICAL's
Thermo Fisher Scientific
EMD Millipore Corporation
PBS Biotech
Global Bioprocessing Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bioprocessing Systems market, Segment by Type:
Upstream
Downstream
Single Use
Integrated
Global Bioprocessing Systems market, by Application
Vaccine Development
Cell Therapy and Plant Cell Cultivation
Filters
Tissue Engineering
Biosensors
Bioreactors and Mixers
Plasma Fractionation
Chromatography
Bio-therapeutic Molecule Production
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bioprocessing Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Bioprocessing Systems
1.1 Bioprocessing Systems Market Overview
1.1.1 Bioprocessing Systems Product Scope
1.1.2 Bioprocessing Systems Market Status and Outlook
1.2 Global Bioprocessing Systems Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bioprocessing Systems Market Size by Region (2018-2029)
1.4 Global Bioprocessing Systems Historic Market Size by Region (2018-2023)
1.5 Global Bioprocessing Systems Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bioprocessing Systems Market Size (2018-2029)
1.6.1 North America Bioprocessing Systems Market Size (2018-2029)
1.6.2 Europe Bioprocessing Systems Market Size (2018-2029)
1.6.3 Asia-Pacific Bioprocessing Systems Market Size (2018-2029)
1.6.4 Latin America Bioprocessing Systems Market Size (2018-2029)
1.6.5 Middle East & Africa Bioprocessing Systems Market Size (2018-2029)
2 Bioprocessing Systems Market by Type
2.1 Introduction
2.1.1 Upstream
2.1.2 Downstream
2.1.3 Single Use
2.1.4 Integrated
2.2 Global Bioprocessing Systems Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bioprocessing Systems Historic Market Size by Type (2018-2023)
2.2.2 Global Bioprocessing Systems Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bioprocessing Systems Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bioprocessing Systems Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bioprocessing Systems Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bioprocessing Systems Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bioprocessing Systems Revenue Breakdown by Type (2018-2029)
3 Bioprocessing Systems Market Overview by Application
3.1 Introduction
3.1.1 Vaccine Development
3.1.2 Cell Therapy and Plant Cell Cultivation
3.1.3 Filters
3.1.4 Tissue Engineering
3.1.5 Biosensors
3.1.6 Bioreactors and Mixers
3.1.7 Plasma Fractionation
3.1.8 Chromatography
3.1.9 Bio-therapeutic Molecule Production
3.2 Global Bioprocessing Systems Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bioprocessing Systems Historic Market Size by Application (2018-2023)
3.2.2 Global Bioprocessing Systems Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bioprocessing Systems Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bioprocessing Systems Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bioprocessing Systems Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bioprocessing Systems Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bioprocessing Systems Revenue Breakdown by Application (2018-2029)
4 Bioprocessing Systems Competition Analysis by Players
4.1 Global Bioprocessing Systems Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bioprocessing Systems as of 2022)
4.3 Date of Key Players Enter into Bioprocessing Systems Market
4.4 Global Top Players Bioprocessing Systems Headquarters and Area Served
4.5 Key Players Bioprocessing Systems Product Solution and Service
4.6 Competitive Status
4.6.1 Bioprocessing Systems Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Lonza
5.1.1 Lonza Profile
5.1.2 Lonza Main Business
5.1.3 Lonza Bioprocessing Systems Products, Services and Solutions
5.1.4 Lonza Bioprocessing Systems Revenue (US$ Million) & (2018-2023)
5.1.5 Lonza Recent Developments
5.2 Pall Corporation
5.2.1 Pall Corporation Profile
5.2.2 Pall Corporation Main Business
5.2.3 Pall Corporation Bioprocessing Systems Products, Services and Solutions
5.2.4 Pall Corporation Bioprocessing Systems Revenue (US$ Million) & (2018-2023)
5.2.5 Pall Corporation Recent Developments
5.3 GE Healthcare
5.3.1 GE Healthcare Profile
5.3.2 GE Healthcare Main Business
5.3.3 GE Healthcare Bioprocessing Systems Products, Services and Solutions
5.3.4 GE Healthcare Bioprocessing Systems Revenue (US$ Million) & (2018-2023)
5.3.5 Nordson MEDICAL's Recent Developments
5.4 Nordson MEDICAL's
5.4.1 Nordson MEDICAL's Profile
5.4.2 Nordson MEDICAL's Main Business
5.4.3 Nordson MEDICAL's Bioprocessing Systems Products, Services and Solutions
5.4.4 Nordson MEDICAL's Bioprocessing Systems Revenue (US$ Million) & (2018-2023)
5.4.5 Nordson MEDICAL's Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Bioprocessing Systems Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Bioprocessing Systems Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 EMD Millipore Corporation
5.6.1 EMD Millipore Corporation Profile
5.6.2 EMD Millipore Corporation Main Business
5.6.3 EMD Millipore Corporation Bioprocessing Systems Products, Services and Solutions
5.6.4 EMD Millipore Corporation Bioprocessing Systems Revenue (US$ Million) & (2018-2023)
5.6.5 EMD Millipore Corporation Recent Developments
5.7 PBS Biotech
5.7.1 PBS Biotech Profile
5.7.2 PBS Biotech Main Business
5.7.3 PBS Biotech Bioprocessing Systems Products, Services and Solutions
5.7.4 PBS Biotech Bioprocessing Systems Revenue (US$ Million) & (2018-2023)
5.7.5 PBS Biotech Recent Developments
6 North America
6.1 North America Bioprocessing Systems Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bioprocessing Systems Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bioprocessing Systems Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bioprocessing Systems Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bioprocessing Systems Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bioprocessing Systems Market Dynamics
11.1 Bioprocessing Systems Industry Trends
11.2 Bioprocessing Systems Market Drivers
11.3 Bioprocessing Systems Market Challenges
11.4 Bioprocessing Systems Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
